Subscribe Indegene Ltd; Anand Rathi

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

live

• bselive
• nselive

Volume

Todays L/H

More

×

Anand Rathi, IPO report on Indegene Ltd

Incorporated on October 16, 1998, Indegene is a Provider of digitalled commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech and medical devices companies and the sales and marketing of their products. Their solutions enable life sciences companies to develop products, launch them in the market, and drive sales through their life cycle in a more effective, efficient and modern manner. The company achieves this by combining over 2 decades of healthcare domain expertise and fit-forpurpose technology. Their portfolio of solutions covers all aspects of commercial, medical, regulatory, and R&D operations of life sciences companies. Company’s Enterprise Commercial Solutions and Omnichannel Activation solutions cater to the commercial functions of life sciences companies while their Enterprise Medical Solutions and Enterprise Clinical Solutions cater to their medical and R&D functions. Enterprise Commercial Solutions primarily involve assisting life sciences companies with their digital marketing operations.

Valuation and Outlook

At the upper price band company is valued at P/E of 40.6x with a market cap of ₹10,814 million post issue of equity shares. We believe that valuation of the company is fairly priced and recommend a “Subscribe” rating to the IPO.

For all IPO report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

06052024 -Indegene -IPO - anand